doi: 10.1007/BF01932334.
Studies on the hydrolysis of bradykinin by angiotensin-converting enzyme (kininase II)
- PMID: 214326
- DOI: 10.1007/BF01932334
Item in Clipboard
Studies on the hydrolysis of bradykinin by angiotensin-converting enzyme (kininase II)
Experientia.
.
Abstract
Arg-Pro-Pro-Gly-Phe, the N-terminal pentapeptide of bradykinin, is not an inhibitor of angiotensin-converting enzyme and is not hydrolyzed by the enzyme. Arg-Pro-Pro, the N-terminal tripeptide is a relatively potent (IC50 = 2.3 X 10(6) M) inhibitor but its higher homolog. Gly-Arg-Met-Lys-Arg-Pro-Pro is not an inhibitor of angiotensin-converting enzyme.
Similar articles
-
Mechanism of digestion of bradykinin and lysylbradykinin (kallidin) in human serum. Role of carboxypeptidase, angiotensin-converting enzyme and determination of final degradation products.Biochem Pharmacol. 1989 Mar 15;38(6):993-1000. doi: 10.1016/0006-2952(89)90290-6. Biochem Pharmacol. 1989. PMID: 2539165
-
Tripeptidyl carboxypeptidase activity of kininase II (angiotensin-converting enzyme).Biochim Biophys Acta. 1981 Dec 15;662(2):300-7. doi: 10.1016/0005-2744(81)90042-5. Biochim Biophys Acta. 1981. PMID: 6274413
-
Selectivity of converting-enzyme inhibitors for angiotensin I versus bradykinin hydrolysis reactions.J Pharm Sci. 1990 May;79(5):384-8. doi: 10.1002/jps.2600790504. J Pharm Sci. 1990. PMID: 2161922
-
Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies.Peptides. 2004 Mar;25(3):521-5. doi: 10.1016/j.peptides.2003.12.010. Peptides. 2004. PMID: 15134871 Review.
-
Pharmacology of angiotensin converting enzyme inhibitors. A review.Am J Med. 1986 Oct 31;81(4C):13-8. doi: 10.1016/0002-9343(86)90939-3. Am J Med. 1986. PMID: 3022580 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous